Patient Reported Outcomes in High-Risk Prostate Cancer Patients with or without Testosterone Recovery after Androgen Deprivation Therapy

A. Nabid, N. Carrier,A. G. Martin,J. P. Bahary, P. Vavassis, S. T. Vass,B. Bahoric,R. Archambault, F. Vincent, R. Bettahar, L. Souhami

International journal of radiation oncology, biology, physics（2023）

引用 0|浏览2

暂无评分

摘要

T recoverypost long-term ADT is associated with a significantly improved QOL in patients with HRPC. Considering similar prostate cancer clinical outcomes and faster T recovery, our results suggest that 18m ADT may be the most appropriate ADT treatment duration for these patients.

查看译文

关键词

prostate cancer,testosterone recovery,androgen,high-risk

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要